New Horizons In Medical Imaging: An Interview With Siemens’ Gregory Sorensen
Medtech Insight interviews Gregory Sorensen, MD, CEO of Siemens Healthcare, North America
Marketplace uncertainty and pressures to reduce costs have had a major impact on the market for medical imaging technologies. Medtech Insight interviews Gregory Sorensen, MD, Siemens Healthcare’s CEO for North America about what’s on the horizon for the industry.
You may also be interested in...
Prominent radiologists and researchers discussed how best to convey risks associated with medical imaging at a Dec. 8-9 meeting in Washington, D.C.
Siemens will begin shipments this summer of its Biograph mMR system, the first device to simultaneously perform full-body PET and MRI scans, following receipt of 510(k) clearance on June 10.
Finding growth opportunities in an era of constrained spending and health care reform is not an easy task, but an increasing number of companies operating in the diagnostics space are taking aim at one underserved area they believe will be a big winner in the years ahead: Alzheimer’s disease. This is a field still in its infancy and the risk of failure remains high. But as research progresses, it’s becoming clear that advances in AD diagnostics could play a major role in reducing that risk.